S2 Ep22: Can GLP-1 Therapy Revolutionize Chronic Skin Treatment?

About this episode

This episode discusses the potential of GLP-1 therapy in treating chronic skin conditions with insights from dermatologist Daniel Walker.

In this episode, board-certified dermatologist of US Dermatology Partners, Daniel Walker, MD, FAAD, shares emerging insights into the expanding role of GLP-1 receptor agonists beyond their primary use in diabetes and weight loss, highlighting their promising—yet still investigational—impact on inflammatory skin diseases such as psoriasis and HS.

People in this episode

Guest: Daniel Walker, MD, FAAD

Topics covered

• GLP-1 therapy
• chronic skin treatment
• inflammatory skin diseases
• psoriasis
• HS
• dermatology
• medical insights

Keywords

• GLP-1
• chronic skin treatment
• psoriasis
• HS
• dermatology
• inflammatory skin diseases
• weight loss
• diabetes

Mentioned in this episode

Organizations: US Dermatology Partners

Products: GLP-1 receptor agonists

Books & works: Can GLP-1 Therapy Revolutionize Chronic Skin Treatment?

More episodes of The Cutaneous Connection

• S2 Ep24: Debunking Allergy Myths and the Future of Atopic Dermatitis Treatment · May 7, 2026 · 18 min
• S2 Ep23: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis · May 1, 2026 · 10 min
• S2 Ep21: By the Skin of Your Teeth with The Spizuoco Sisters · March 23, 2026 · 19 min
• S2 Ep20: Skin Changes, Hormones, and the Menopause Conversation in Aesthetics · March 5, 2026 · 15 min
• S2 Ep19: Highlighting Voices of Patients With Indolent Systemic Mastocytosis · February 21, 2026 · 32 min
• 19: Utilizing the National Eczema Association's EczemaWise App for Clinicians and Patients · September 10, 2025 · 24 min